Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Diabetes Technology & Therapeutics
|
July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study
Thomas Blevins, Wendy Lane, David Rodbard, et al.
Journal of Diabetes and Its Complications
|
September 18, 2021
Individualized HbA1c target selection and achievement in the Multinational Observational Study Assessing Insulin Use (MOSA1c) type 2 diabetes study
A Enrique Caballero, Beth L Nordstrom, Birong Liao, et al.
Diabetes, Obesity & Metabolism
|
December 23, 2019
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
George Grunberger, Anuj Bhargava, Trang Ly, et al.
Diabetes Technology & Therapeutics
|
August 18, 2017
Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8
Cynthia Harris, Thomas Forst, Tim Heise, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2026
Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity
Andreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Current Medical Research and Opinion
|
May 4, 2023
Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning
Emily R Hankosky, Michelle L Katz, Ludi Fan, et al.
Advances in Therapy
|
March 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials
Andreea Ciudin, Helene Sapin, Ludi Fan, et al.
Diabetes Research and Clinical Practice
|
May 2, 2024
Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting
Robert Brett McQueen, Magaly Perez-Nieves, G Todd Alonso, et al.
Diabetes, Obesity & Metabolism
|
June 20, 2025
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
Andreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Current Medical Research and Opinion
|
October 27, 2020
Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study
Carolina Piras de Oliveira, Beth D Mitchell, Ludi Fan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Diabetes Technology & Therapeutics
|
July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study
Thomas Blevins, Wendy Lane, David Rodbard, et al.
Journal of Diabetes and Its Complications
|
September 18, 2021
Individualized HbA1c target selection and achievement in the Multinational Observational Study Assessing Insulin Use (MOSA1c) type 2 diabetes study
A Enrique Caballero, Beth L Nordstrom, Birong Liao, et al.
Diabetes, Obesity & Metabolism
|
December 23, 2019
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
George Grunberger, Anuj Bhargava, Trang Ly, et al.
Diabetes Technology & Therapeutics
|
August 18, 2017
Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8
Cynthia Harris, Thomas Forst, Tim Heise, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2026
Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity
Andreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Current Medical Research and Opinion
|
May 4, 2023
Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning
Emily R Hankosky, Michelle L Katz, Ludi Fan, et al.
Advances in Therapy
|
March 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials
Andreea Ciudin, Helene Sapin, Ludi Fan, et al.
Diabetes Research and Clinical Practice
|
May 2, 2024
Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting
Robert Brett McQueen, Magaly Perez-Nieves, G Todd Alonso, et al.
Diabetes, Obesity & Metabolism
|
June 20, 2025
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
Andreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Current Medical Research and Opinion
|
October 27, 2020
Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study
Carolina Piras de Oliveira, Beth D Mitchell, Ludi Fan, et al.
Page
of 4